NIAID Prioritizes Development Of Universal Influenza Vaccine
United Press International: NIH agency’s priority: Developing universal flu vaccine
“The National Institute of Allergy and Infectious Diseases has announced a new priority: developing a universal influenza vaccine that can protect people of all ages against multiple flu strains. The NIAID, which is part of the National Institutes of Health, on Wednesday detailed a new strategic plan for addressing the research areas essential to creating a safe and effective universal influenza vaccine. The agency also published a paper Wednesday in the Journal of Infectious Disease…” (Cone, 2/28).